| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 4e-13 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |